Fair Value Measurements (Tables)
|
3 Months Ended |
Mar. 31, 2026 |
| Fair Value Disclosures [Abstract] |
|
| Schedule of Assets and Liabilities Accounted for at Fair Value on a Recurring Basis |
The following tables set forth, by level, the Company’s assets and liabilities that were accounted for at fair value on a recurring basis as of March 31, 2026 and December 31, 2025 (in millions).
| | | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements at March 31, 2026 | | | Level 1 | | Level 2 | | Level 3 | | Total | | Assets: | | | | | | | | | Inventories carried at market | $ | — | | | $ | 4,328 | | | $ | 3,242 | | | $ | 7,570 | | | Unrealized derivative gains: | | | | | | | | | Commodity contracts | — | | | 333 | | | 540 | | | 873 | | | Foreign currency contracts | — | | | 314 | | | — | | | 314 | | | Interest rate contracts | — | | | 13 | | | — | | | 13 | | | | | | | | | | | Cash equivalents | 65 | | | — | | | — | | | 65 | | | Marketable securities | 33 | | | — | | | — | | | 33 | | | Segregated investments and restricted cash equivalents | 1,583 | | | — | | | — | | | 1,583 | | | Total Assets | $ | 1,681 | | | $ | 4,988 | | | $ | 3,782 | | | $ | 10,451 | | | | | | | | | | | Liabilities: | | | | | | | | | Unrealized derivative losses: | | | | | | | | | Commodity contracts | $ | — | | | $ | 568 | | | $ | 634 | | | $ | 1,202 | | | Foreign currency contracts | — | | | 166 | | | — | | | 166 | | | | | | | | | | | | | | | | | | | Inventory-related payables | — | | | 1,467 | | | 30 | | | 1,497 | | | Total Liabilities | $ | — | | | $ | 2,201 | | | $ | 664 | | | $ | 2,865 | |
| | | | | | | | | | | | | | | | | | | | | | | | | Fair Value Measurements at December 31, 2025 | | | Level 1 | | Level 2 | | Level 3 | | Total | | Assets: | | | | | | | | | Inventories carried at market | $ | — | | | $ | 3,549 | | | $ | 2,673 | | | $ | 6,222 | | | Unrealized derivative gains: | | | | | | | | | Commodity contracts | — | | | 310 | | | 512 | | | 822 | | | Foreign currency contracts | — | | | 108 | | | — | | | 108 | | | Interest rate contracts | — | | | 17 | | | — | | | 17 | | | Cash equivalents | 280 | | | — | | | — | | | 280 | | | Marketable securities | 32 | | | — | | | — | | | 32 | | | Segregated investments and restricted cash equivalents | 1,771 | | | — | | | — | | | 1,771 | | | Total Assets | $ | 2,083 | | | $ | 3,984 | | | $ | 3,185 | | | $ | 9,252 | | | | | | | | | | | Liabilities: | | | | | | | | | Unrealized derivative losses: | | | | | | | | | Commodity contracts | $ | — | | | $ | 300 | | | $ | 313 | | | $ | 613 | | | Foreign currency contracts | — | | | 144 | | | — | | | 144 | | | | | | | | | | | | | | | | | | | Inventory-related payables | — | | | 714 | | | 16 | | | 730 | | | Total Liabilities | $ | — | | | $ | 1,158 | | | $ | 329 | | | $ | 1,487 | |
|
| Schedule of Roll Forward of Assets Measured at Fair Value on a Recurring Basis Using Unobservable Inputs |
The following table presents a roll forward of assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2026 (in millions).
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Assets | | Liabilities | | March 31, 2026 | | March 31, 2026 | | | Inventories Carried at Market | | Commodity Derivative Contracts Gains | | Total Assets | | Inventory-related Payables | | Commodity Derivative Contracts Losses | | Total Liabilities | | Opening balance, January 1, 2026 | $ | 2,673 | | | $ | 512 | | | $ | 3,185 | | | $ | 16 | | | $ | 313 | | | $ | 329 | | Increase in unrealized gains included in Cost of products sold | 375 | | | 290 | | | 665 | | | — | | | — | | | — | | Increase in unrealized losses included in Cost of products sold | — | | | — | | | — | | | 1 | | | 554 | | | 555 | | Realized (decreases) included in Cost of products sold | (246) | | | — | | | (246) | | | (2) | | | — | | | (2) | | | Purchases | 4,550 | | | — | | | 4,550 | | | 15 | | | — | | | 15 | | | Sales | (4,421) | | | — | | | (4,421) | | | (1) | | | — | | | (1) | | | Settlements | — | | | (249) | | | (249) | | | — | | | (222) | | | (222) | | | Transfers into Level 3 | 495 | | | 10 | | | 505 | | | 1 | | | 28 | | | 29 | | | Transfers out of Level 3 | (184) | | | (23) | | | (207) | | | — | | | (39) | | | (39) | | | Closing balance, March 31, 2026 | $ | 3,242 | | | $ | 540 | | | $ | 3,782 | | | $ | 30 | | | $ | 634 | | | $ | 664 | |
The following table presents a roll forward of assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2025 (in millions).
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Assets | | Liabilities | | March 31, 2025 | | March 31, 2025 | | | Inventories Carried at Market | | Commodity Derivative Contracts Gains | | Total Assets | | Inventory-related Payables | | Commodity Derivative Contracts Losses | | Total Liabilities | | Opening balance, January 1, 2025 | $ | 3,031 | | | $ | 427 | | | $ | 3,458 | | | $ | 88 | | | $ | 405 | | | $ | 493 | | Increase in unrealized gains included in Cost of products sold | 97 | | | 213 | | | 310 | | | — | | | — | | | — | | | Increase (decrease) in unrealized losses included in Cost of products sold | — | | | — | | | — | | | (1) | | | 194 | | | 193 | | | Realized increases (decreases) included in Cost of products sold | 55 | | | — | | | 55 | | | (2) | | | — | | | (2) | | | Purchases | 4,086 | | | — | | | 4,086 | | | 3 | | | — | | | 3 | | | Sales | (4,578) | | | — | | | (4,578) | | | (36) | | | — | | | (36) | | | Settlements | — | | | (228) | | | (228) | | | — | | | (277) | | | (277) | | | Transfers into Level 3 | 571 | | | 113 | | | 684 | | | — | | | 35 | | | 35 | | | Transfers out of Level 3 | (159) | | | (17) | | | (176) | | | — | | | (5) | | | (5) | | | Closing balance, March 31, 2025 | $ | 3,103 | | | $ | 508 | | | $ | 3,611 | | | $ | 52 | | | $ | 352 | | | $ | 404 | |
|
| Schedule of Roll Forward of Liabilities Measured at Fair Value on a Recurring Basis Using Unobservable Inputs |
The following table presents a roll forward of assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2026 (in millions).
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Assets | | Liabilities | | March 31, 2026 | | March 31, 2026 | | | Inventories Carried at Market | | Commodity Derivative Contracts Gains | | Total Assets | | Inventory-related Payables | | Commodity Derivative Contracts Losses | | Total Liabilities | | Opening balance, January 1, 2026 | $ | 2,673 | | | $ | 512 | | | $ | 3,185 | | | $ | 16 | | | $ | 313 | | | $ | 329 | | Increase in unrealized gains included in Cost of products sold | 375 | | | 290 | | | 665 | | | — | | | — | | | — | | Increase in unrealized losses included in Cost of products sold | — | | | — | | | — | | | 1 | | | 554 | | | 555 | | Realized (decreases) included in Cost of products sold | (246) | | | — | | | (246) | | | (2) | | | — | | | (2) | | | Purchases | 4,550 | | | — | | | 4,550 | | | 15 | | | — | | | 15 | | | Sales | (4,421) | | | — | | | (4,421) | | | (1) | | | — | | | (1) | | | Settlements | — | | | (249) | | | (249) | | | — | | | (222) | | | (222) | | | Transfers into Level 3 | 495 | | | 10 | | | 505 | | | 1 | | | 28 | | | 29 | | | Transfers out of Level 3 | (184) | | | (23) | | | (207) | | | — | | | (39) | | | (39) | | | Closing balance, March 31, 2026 | $ | 3,242 | | | $ | 540 | | | $ | 3,782 | | | $ | 30 | | | $ | 634 | | | $ | 664 | |
The following table presents a roll forward of assets and liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the three months ended March 31, 2025 (in millions).
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Assets | | Liabilities | | March 31, 2025 | | March 31, 2025 | | | Inventories Carried at Market | | Commodity Derivative Contracts Gains | | Total Assets | | Inventory-related Payables | | Commodity Derivative Contracts Losses | | Total Liabilities | | Opening balance, January 1, 2025 | $ | 3,031 | | | $ | 427 | | | $ | 3,458 | | | $ | 88 | | | $ | 405 | | | $ | 493 | | Increase in unrealized gains included in Cost of products sold | 97 | | | 213 | | | 310 | | | — | | | — | | | — | | | Increase (decrease) in unrealized losses included in Cost of products sold | — | | | — | | | — | | | (1) | | | 194 | | | 193 | | | Realized increases (decreases) included in Cost of products sold | 55 | | | — | | | 55 | | | (2) | | | — | | | (2) | | | Purchases | 4,086 | | | — | | | 4,086 | | | 3 | | | — | | | 3 | | | Sales | (4,578) | | | — | | | (4,578) | | | (36) | | | — | | | (36) | | | Settlements | — | | | (228) | | | (228) | | | — | | | (277) | | | (277) | | | Transfers into Level 3 | 571 | | | 113 | | | 684 | | | — | | | 35 | | | 35 | | | Transfers out of Level 3 | (159) | | | (17) | | | (176) | | | — | | | (5) | | | (5) | | | Closing balance, March 31, 2025 | $ | 3,103 | | | $ | 508 | | | $ | 3,611 | | | $ | 52 | | | $ | 352 | | | $ | 404 | |
|
| Schedule of Unobservable Price Components Present in the Level 3 Valuations of Assets and Liabilities Measured at Fair Value on a Recurring Basis |
The following table sets forth the weighted average percentage of the unobservable price components included in the Company’s Level 3 valuations as of March 31, 2026 and December 31, 2025. The Company’s Level 3 measurements may include basis only, transportation cost only, or both price components. | | | | | | | | | | | | | | | | | | | | | | | | | Weighted Average % of Total Price | | March 31, 2026 | | December 31, 2025 | | Component Type | Assets | | Liabilities | | Assets | | Liabilities | | Inventories and Inventory-Related Payables | | | | | | | | | Basis | 19.4 | % | | 11.4 | % | | 21.1 | % | | 9.0 | % | | Transportation cost | 14.4 | % | | — | % | | 22.4 | % | | — | % | | | | | | | | | | Commodity Derivative Contracts | | | | | | | | | Basis | 20.0 | % | | 20.5 | % | | 23.3 | % | | 23.6 | % | | Transportation cost | 20.4 | % | | 23.3 | % | | 25.7 | % | | — | % |
|